Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Clinical trial NCT05342194 · RECRUITING
Trial details
- NCT number
- NCT05342194
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2027-05-31
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.